{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "STU", "shortName": "Infant Bacterial Therapeutics A", "longName": "Infant Bacterial Therapeutics AB (publ)", "messageBoardId": "finmb_325472579", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 2.3195853, "regularMarketPrice": 3.97, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.40120664, "fiftyTwoWeekLow": 3.7, "fiftyTwoWeekHigh": 6.63, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.47, "sharesOutstanding": 10848400, "bookValue": 5.826, "fiftyDayAverage": 4.1256, "fiftyDayAverageChange": -0.15559983, "fiftyDayAverageChangePercent": -0.03771569, "twoHundredDayAverage": 4.924225, "twoHundredDayAverageChange": -0.9542248, "twoHundredDayAverageChangePercent": -0.19378173, "marketCap": 50014060, "priceToBook": 0.6814281, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.089999914, "regularMarketTime": 1683890762, "regularMarketDayHigh": 3.97, "regularMarketDayRange": "3.85 - 3.97", "regularMarketDayLow": 3.85, "regularMarketVolume": 0, "regularMarketPreviousClose": 3.88, "bid": 3.97, "ask": 4.22, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "financialCurrency": "SEK", "regularMarketOpen": 3.85, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.26999998, "fiftyTwoWeekLowChangePercent": 0.07297297, "fiftyTwoWeekRange": "3.7 - 6.63", "fiftyTwoWeekHighChange": -2.66, "firstTradeDateMilliseconds": 1582009200000, "symbol": "9IB.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Bryggargatan 10", "city": "Stockholm", "zip": "111 21", "country": "Sweden", "phone": "46 7 62 19 37 38", "website": "https://www.ibtherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe disease in infants. The company was incorporated in 2011 and is based in Stockholm, Sweden.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Mr. Staffan  Stromberg Ph.D.", "age": 55, "title": "Chief Exec. Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Molander", "age": 57, "title": "Chief Commercial Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Maria  Ekdahl", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anders  Kronstr\u00f6m", "age": 55, "title": "Chief Operating Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Jonas  Rastad M.D., Ph.D.", "age": 72, "title": "Chief Medical Officer & Chief Scientific Officer", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}